Atlas Trials

Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer

Clinical trial NCT06926088 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06926088
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Advanced Breast Cancer
Start date
2016-12-01
Primary completion
2025-12-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.